🍪 Our Cookies

This website uses cookies, pixel tags, and similar technologies (“Cookies”) for the purpose of enabling site operations and for performance, personalisation, and marketing purposes. We use our own Cookies and some from third parties. Only essential Cookies are used by default. By clicking “Accept All” you consent to the use of non-essential Cookies (i.e., functional, analytics, and marketing Cookies) and the related processing of personal data. You can manage your consent preferences by clicking Manage Preferences. You may withdraw a consent at any time by using the link “Cookie Preferences” in the footer of our website.

Our Privacy Notice is accessible here. To learn more about the use of Cookies on our website, please view our Cookie Notice.

US LevFin Wrap — Altice and Asurion put spotlight on CLOs, tricky refis in play for Herbalife and Russell Investments

Share

Market Wrap

US LevFin Wrap — Altice and Asurion put spotlight on CLOs, tricky refis in play for Herbalife and Russell Investments

David Bell's avatar
Bill Weisbrod's avatar
Emily Fasold's avatar
  1. David Bell
  2. +Bill Weisbrod
  3. + 1 more
7 min read

Drama across the pond in Altice’s sprawling capital stack kept US leveraged finance investors on their toes this week, while some trickier deals such as Russell Investments labored to get done in a primary market that’s still cautious around riskier names.

The French telecom company’s faceoff with investors over how €2.1bn of proceeds from asset sales will be used — and talk of haircuts to reduce leverage — has spooked holders of Altice France debt, which is held widely across both US and European CLOs. (We’ve written nine articles on the situation over the past two weeks, click here if you missed any).

Read all our public content for free

We won't spam. You can unsubscribe at any time.

What are you waiting for?

Try it out
  • We're trusted by 9 of the top 10 Investment Banks